Haemoglobin targets: we were wrong, time to move on
- 1 February 2007
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 369 (9559) , 346-350
- https://doi.org/10.1016/s0140-6736(07)60165-2
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysisThe Lancet, 2007
- Haemoglobin concentrations in chronic kidney diseaseThe Lancet, 2006
- Anemia and Cardiovascular RiskJournal of the American Society of Nephrology, 2006
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- Correction of Anemia — Payoffs and ProblemsNew England Journal of Medicine, 2006
- Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and AnemiaNew England Journal of Medicine, 2006
- Evidence-Based Systematic Literature Review of Hemoglobin/Hematocrit and All-Cause Mortality in Dialysis PatientsAmerican Journal of Kidney Diseases, 2006
- Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)Nephrology Dialysis Transplantation, 2004
- Should Hemoglobin be Normalized in Patients with Chronic Kidney Disease?Seminars in Dialysis, 2002
- The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and EpoetinNew England Journal of Medicine, 1998